| CON (n = 26) | NO-T1D (n = 36) | LT-T1D (n = 20) | T2D (n = 22) | P value |
---|---|---|---|---|---|
Gender, Men (n) | |||||
Age (years) | 22.2 ± 9.3 | 26.1 ± 14.2 | 27.9 ± 15.3 | 47.3 ± 12.2a,b,c |  < 0.001 |
  < 18 years, n (%) | 10 (38) | 12 (33) | 6 (30) | 0 (0) |  |
  ≥ 18 years, n (%) | 16 (62) | 24 (67) | 14 (70) | 22 (100) |  |
Onset-age (years) | / | 26.1 ± 14.3 | 24.0 ± 15.6 | 47.1 ± 12.8b,c |  < 0.001 |
Duration (months) | / | 2.0 ± 2.1 | 45.8 ± 23.5 | 1.3 ± 1.3c |  < 0.001 |
BMI (kg/m2) | 20.8 ± 2.5 | 19.5 ± 3.0 | 20.6 ± 3.3 | 24.0 ± 2.5a,b,c |  < 0.001 |
DK or DKA (%) | 0.0 | 75.0 | 55.0 | 9.1 |  < 0.001 |
Family History of Diabetes (%) | 30.8 | 25.0 | 15.0 | 54.5 | 0.033 |
HbA1c (mmol/mol) | 34 ± 3.3 | 84 ± 31.7 | 65 ± 26.2 | 96 ± 31.7 |  |
HbA1c (%) | 5.3 ± 0.3 | 9.8 ± 2.9a | 8.1 ± 2.4 a | 10.9 ± 2.9a,c |  < 0.001 |
FPG (mmol/l) | 4.3 ± 0.5 | 7.4 ± 2.8a | 10.1 ± 4.8 a,b | 9.5 ± 3.4a,b |  < 0.001 |
2hPG (mmol/l) | 4.5 ± 1.3 | 13.5 ± 4.6a | 13.3 ± 3.6 a | 15.8 ± 3.6a |  < 0.001 |
FCP (pmol/l) | 558.4 (489.2, 719.0) | 226.0 (141.4, 323.2)a | 32.3 (9.8, 242.3)a | 520.4 (348.5, 789.1)b,c |  < 0.001 |
2hCP (pmol/l) | 1717 (1321.0, 2261.0) | 425.5 (243.2, 795.8)a | 82.9 (16.5, 387.0)a | 964.9 (747.61782.0)b,c |  < 0.001 |
IAA+ | 0 | 2 | 3 | 0 | Â |
ICA+ | 0 | 22 | 5 | 0 | Â |
GADA+ | 0 | 34 | 13 | 0 | Â |
IA2A+ | 0 | 24 | 8 | 0 | Â |
No. of autoantibodies | |||||
 4 |  | 1 | 1 |  |  |
 3 |  | 15 | 1 |  |  |
 2 |  | 13 | 8 |  |  |
 1 |  | 7 | 5 |  |  |